139 related articles for article (PubMed ID: 24171833)
21. Risk factors for pterygium recurrence after surgical excision with combined conjunctival autograft (CAG) and intraoperative antimetabolite use.
Olusanya BA; Ogun OA; Bekibele CO; Ashaye AO; Baiyeroju AM; Fasina O; Ogundipe AO; Ibrahim AO
Afr J Med Med Sci; 2014 Mar; 43(1):35-40. PubMed ID: 25335376
[TBL] [Abstract][Full Text] [Related]
22. Pterygia: pathogenesis and the role of subconjunctival bevacizumab in treatment.
Mauro J; Foster CS
Semin Ophthalmol; 2009; 24(3):130-4. PubMed ID: 19437347
[TBL] [Abstract][Full Text] [Related]
23. Ocular surface changes in recurrent pterygium cases post-operatively treated with 5-fluorouracil subconjunctival injections.
García Tirado A; Boto de Los Bueis A; Rivas Jara L
Eur J Ophthalmol; 2019 Jan; 29(1):9-14. PubMed ID: 29580102
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of curcumin in inducing apoptosis and inhibiting the expression of VEGF in human pterygium fibroblasts.
Lu CW; Hao JL; Yao L; Li HJ; Zhou DD
Int J Mol Med; 2017 May; 39(5):1149-1154. PubMed ID: 28393179
[TBL] [Abstract][Full Text] [Related]
25. Cyclooxygenase-2-expressing macrophages in human pterygium co-express vascular endothelial growth factor.
Park CY; Choi JS; Lee SJ; Hwang SW; Kim EJ; Chuck RS
Mol Vis; 2011; 17():3468-80. PubMed ID: 22219642
[TBL] [Abstract][Full Text] [Related]
26. Expression of Peroxiredoxin 2 and Vascular Endothelial Growth Factor Receptor 2 in Pterygium.
Wang Y; Lin J; Chen L; Wang L; Hao P; Han R; Ying M; Li X
Cornea; 2017 Jul; 36(7):841-844. PubMed ID: 28489720
[TBL] [Abstract][Full Text] [Related]
27. Angiogenesis in pterygium: morphometric and immunohistochemical study.
Marcovich AL; Morad Y; Sandbank J; Huszar M; Rosner M; Pollack A; Herbert M; Bar-Dayan Y
Curr Eye Res; 2002 Jul; 25(1):17-22. PubMed ID: 12518239
[TBL] [Abstract][Full Text] [Related]
28. Phase I study of subconjunctival ranibizumab in patients with primary pterygium undergoing pterygium surgery.
Galor A; Yoo SH; Piccoli FV; Schmitt AJ; Chang V; Perez VL
Am J Ophthalmol; 2010 Jun; 149(6):926-931.e2. PubMed ID: 20417925
[TBL] [Abstract][Full Text] [Related]
29. Targeted delivery of mitomycin C-loaded and LDL-conjugated mesoporous silica nanoparticles for inhibiting the proliferation of pterygium subconjunctival fibroblasts.
Wu M; Wang S; Wang Y; Zhang F; Shao T
Exp Eye Res; 2020 Aug; 197():108124. PubMed ID: 32598971
[TBL] [Abstract][Full Text] [Related]
30. Correlation of vascular endothelial growth factor and CD105-microvascular density in primary pterygium.
Zhang J; Zhang M; Li X; Zheng T; Mu G; Liu W; Xie H; Liu X
J Huazhong Univ Sci Technolog Med Sci; 2011 Aug; 31(4):560. PubMed ID: 21823022
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of subconjunctival 5-fluorouracil and triamcinolone injection in impending recurrent pterygium.
Prabhasawat P; Tesavibul N; Leelapatranura K; Phonjan T
Ophthalmology; 2006 Jul; 113(7):1102-9. PubMed ID: 16730066
[TBL] [Abstract][Full Text] [Related]
32. Expression of vascular endothelial growth factor C in human pterygium.
Fukuhara J; Kase S; Ohashi T; Ando R; Dong Z; Noda K; Ohguchi T; Kanda A; Ishida S
Histochem Cell Biol; 2013 Feb; 139(2):381-9. PubMed ID: 22910845
[TBL] [Abstract][Full Text] [Related]
33. The effect of subconjunctival ranibizumab on primary pterygium: a pilot study.
Mandalos A; Tsakpinis D; Karayannopoulou G; Tsinopoulos I; Karkavelas G; Chalvatzis N; Dimitrakos S
Cornea; 2010 Dec; 29(12):1373-9. PubMed ID: 20856107
[TBL] [Abstract][Full Text] [Related]
34. 5-fluorouracil vs. beta-irradiation in the prevention of pterygium recurrence.
Bekibele CO; Baiyeroju AM; Ajayi BG
Int J Clin Pract; 2004 Oct; 58(10):920-3. PubMed ID: 15587769
[TBL] [Abstract][Full Text] [Related]
35. Expression of neurotrophic factors in human primary pterygeal tissue and selective TNF-alpha-induced stimulation of ciliary neurotrophic factor in pterygeal fibroblasts.
Hong S; Choi JY; Lee HK; Seong GJ; Seo KY; Kim EK; Byeon SH
Exp Toxicol Pathol; 2008 Sep; 60(6):513-20. PubMed ID: 18585018
[TBL] [Abstract][Full Text] [Related]
36. Increasing lymphatic microvessel density in primary pterygia.
Ling S; Liang L; Lin H; Li W; Xu J
Arch Ophthalmol; 2012 Jun; 130(6):735-42. PubMed ID: 22801834
[TBL] [Abstract][Full Text] [Related]
37. Fibroblasts isolated from human pterygia exhibit altered lipid metabolism characteristics.
Peiretti E; Dessì S; Mulas MF; Abete C; Galantuomo MS; Fossarello M
Exp Eye Res; 2006 Sep; 83(3):536-42. PubMed ID: 16696971
[TBL] [Abstract][Full Text] [Related]
38. Postoperative subconjunctival 5-fluorouracil in the management of recurring pterygium.
Pherwani A; Vakil V; Eatamadi H; Singh R; Dua HS
Br J Ophthalmol; 2007 Mar; 91(3):398-9. PubMed ID: 17322471
[No Abstract] [Full Text] [Related]
39. Presence and possible significance of immunohistochemically demonstrable metallothionein expression in pterygium versus pinguecula and normal conjunctiva.
Tsironi S; Ioachim E; Machera M; Aspiotis M; Agnanti N; Psilas K
Eye (Lond); 2001 Feb; 15(Pt 1):89-96. PubMed ID: 11318304
[TBL] [Abstract][Full Text] [Related]
40. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
